Clinical Guidelines for Chronic Cough Phenotyping

Abstract

Chronic cough is a common, often multifactorial symptom presenting significant diagnostic and management challenges in clinical practice. Accurate phenotyping is essential for tailored therapy and improved patient outcomes. This article synthesizes current clinical guidelines, recent advances, and evidence-based strategies for chronic cough phenotyping, offering practical insights for healthcare professionals managing this complex clinical entity.

Introduction

Chronic cough, defined as a cough persisting for more than eight weeks, is a frequent complaint in both primary and specialist care settings. It can significantly impact patients\' quality of life and may signal underlying respiratory or systemic disease. The heterogeneity of underlying etiologies necessitates a systematic approach to phenotyping, which aims to delineate the clinical and pathophysiological subtypes to inform precise management. Recent clinical guidelines emphasize the importance of mechanistic and symptom-based phenotyping, reflecting advances in understanding chronic cough pathogenesis.

Epidemiology / Disease Burden

Chronic cough affects approximately 10% of the adult population globally, with prevalence varying by region and demographic factors. It is more common in women and older adults, and frequently leads to substantial healthcare utilization, including repeated consultations, investigations, and empirical therapies. The disease burden extends beyond physical symptoms, encompassing psychological distress, social impairment, and reduced work productivity. Epidemiological studies underscore the significance of chronic cough as an independent clinical entity warranting focused diagnostic and therapeutic strategies.

Pathophysiology

The pathophysiology of chronic cough is multifaceted, involving peripheral and central sensitization of the cough reflex pathway. Key mechanisms include heightened cough reflex sensitivity, neurogenic inflammation, and dysregulation of sensory nerves. Phenotypes such as cough-variant asthma, eosinophilic bronchitis, gastroesophageal reflux-associated cough, and upper airway cough syndrome reflect distinct underlying mechanisms. Understanding these processes is crucial for targeted interventions, as generic antitussive therapy often fails to address the root cause and may lead to suboptimal outcomes.

Risk Factors

Several risk factors are associated with the development and persistence of chronic cough. These include environmental exposures (smoking, air pollution), occupational hazards, atopy, comorbid conditions (asthma, gastroesophageal reflux disease, chronic rhinosinusitis), female gender, and advancing age. Genetic predisposition and heightened cough reflex sensitivity also play roles in susceptible individuals. Recognizing these risk factors aids clinicians in identifying at-risk populations and informs preventive strategies.

Clinical Features

The clinical presentation of chronic cough is variable, ranging from dry, non-productive cough to productive cough with sputum. Associated symptoms such as wheezing, dyspnea, throat clearing, postnasal drip, and heartburn may provide diagnostic clues to the underlying phenotype. A thorough history and symptom characterization are vital, as is the identification of alarm features (hemoptysis, significant weight loss, persistent fever, or chest pain) that may indicate serious underlying pathology such as malignancy or infection. Clinical features should guide the selection of appropriate diagnostic tests and management pathways.

Diagnosis

The diagnostic approach to chronic cough is stepwise and phenotype-driven. Initial assessment includes a comprehensive history, physical examination, and baseline investigations such as chest radiography and spirometry. Further evaluation is guided by clinical suspicion, with additional tests including methacholine challenge, induced sputum analysis, pH monitoring, and upper airway assessment as indicated. Exclusion of serious causes is paramount, after which common etiologies such as asthma, reflux, and upper airway cough syndrome are systematically investigated. Recent guidelines advocate for a structured diagnostic algorithm that prioritizes phenotype recognition and minimizes unnecessary testing.

Treatment & Management

Management of chronic cough is anchored in the identification and treatment of the underlying phenotype. Asthma-related cough is managed with inhaled corticosteroids and bronchodilators; eosinophilic bronchitis with corticosteroids; reflux-associated cough with proton pump inhibitors and lifestyle modification; and upper airway cough syndrome with antihistamines or intranasal corticosteroids. Refractory or unexplained chronic cough may require neuromodulatory therapy (e.g., gabapentin, pregabalin) targeting cough reflex hypersensitivity. Non-pharmacological interventions, including cough suppression physiotherapy and behavioral therapy, are increasingly recognized for their adjunctive benefits. Treatment response should be monitored, and therapy adjusted according to clinical course and emerging evidence.

Recent Advances / Emerging Therapies

Recent years have witnessed significant advances in the mechanistic understanding and therapeutic landscape of chronic cough. The development of cough hypersensitivity syndrome as a unifying concept has informed new diagnostic and therapeutic approaches. Novel agents targeting P2X3 receptors (e.g., gefapixant) have demonstrated efficacy in refractory chronic cough in phase 3 trials, heralding a new era of mechanism-based therapies. Biomarker-driven phenotyping, advanced imaging, and digital health tools are under investigation to further refine diagnosis and personalize management. Continued research into neurogenic pathways and cough modulation holds promise for future therapeutic breakthroughs.

Guideline Recommendations

Contemporary clinical guidelines from major respiratory societies, including the American College of Chest Physicians (CHEST), European Respiratory Society (ERS), and British Thoracic Society (BTS), converge on the importance of systematic phenotyping in chronic cough management. Key recommendations include: (1) thorough history and physical examination; (2) exclusion of serious underlying disease; (3) stepwise, phenotype-specific diagnostic workup; (4) targeted therapy based on identified phenotype; (5) consideration of neuromodulatory therapy for refractory cases; and (6) patient education and multidisciplinary care. Guidelines highlight the importance of minimizing empirical therapy and advocate for ongoing assessment and adaptation of management strategies based on evolving evidence.

Conclusion

Chronic cough phenotyping represents a paradigm shift in the clinical approach to this challenging symptom. Evidence-based, guideline-driven strategies that integrate mechanistic insights, risk stratification, and patient-centered care are essential for optimizing outcomes. As research continues to elucidate novel pathophysiological mechanisms and therapeutic targets, clinicians must remain agile in incorporating emerging evidence into practice. A systematic, phenotype-driven framework for diagnosis and management not only improves symptom control but also enhances patient quality of life, underscoring the critical importance of precision medicine in chronic cough care.